Adam Sanderson

Adam Sanderson has over 20 years of work experience in the medicinal chemistry field. Adam began their career in 2000 at Eli Lilly and Company as a Research Advisor, a Principal Medicinal Chemist & Group Leader, a Senior Medicinal Chemist, a Medicinal Chemist, and a Synthetic Chemist. In 2021, they joined OMass Therapeutics as the Director of Medicinal Chemistry.

Adam Sanderson completed their Doctor of Philosophy - PhD in Organic Chemistry from The University of Salford between 1996 and 1999. Prior to that, they obtained their Bachelor's degree in Chemistry from The University of Salford between 1993 and 1996.